Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, BridgeBio Pharma Inc (NASDAQ: BBIO) closed at $27.70 down -0.32% from its previous closing price of $27.79. In other words, the price has decreased by -$0.32 from its previous closing price. On the day, 0.73 million shares were traded. BBIO stock price reached its highest trading level at $27.91 during the session, while it also had its lowest trading level at $27.21.
Ratios:
For a deeper understanding of BridgeBio Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.54 and its Current Ratio is at 5.54.
On January 31, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $37.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $58.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $58 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 01 ’24 when Scott Randal W. sold 2,500 shares for $34.00 per share. The transaction valued at 85,000 led to the insider holds 6,500 shares of the business.
Valantine Hannah sold 2,915 shares of BBIO for $110,041 on Feb 15 ’24. The Director now owns 1,764 shares after completing the transaction at $37.75 per share. On Jan 16 ’24, another insider, Valantine Hannah, who serves as the Director of the company, sold 2,915 shares for $37.97 each. As a result, the insider received 110,683 and left with 1,764 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 5183473152 and an Enterprise Value of 6422074368. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.71. Its current Enterprise Value per Revenue stands at 29.379 whereas that against EBITDA is -13.768.
Stock Price History:
Over the past 52 weeks, BBIO has reached a high of $44.32, while it has fallen to a 52-week low of $12.75. The 50-Day Moving Average of the stock is -2.45%, while the 200-Day Moving Average is calculated to be -9.96%.
Shares Statistics:
For the past three months, BBIO has traded an average of 1.68M shares per day and 1404340 over the past ten days. A total of 175.08M shares are outstanding, with a floating share count of 140.85M. Insiders hold about 24.73% of the company’s shares, while institutions hold 70.46% stake in the company. Shares short for BBIO as of 1713139200 were 15073286 with a Short Ratio of 9.00, compared to 1710460800 on 13407125. Therefore, it implies a Short% of Shares Outstanding of 15073286 and a Short% of Float of 12.43.
